Chapter
The Problem With Weight-Loss Medications
48:46 - 1:01:29 (12:42)
Weight-loss medications present an issue due to the lack of data available on their effectiveness and potential side effects. They only seem to work if coupled with a comprehensive approach, which is hard to come by in the US healthcare system.
Clips
This podcast discusses the usage of pharmacotherapy for children and adolescents who require an additional treatment option to manage obesity.
48:46 - 51:54 (03:07)
Summary
This podcast discusses the usage of pharmacotherapy for children and adolescents who require an additional treatment option to manage obesity. The hosts point out that just because previous weight loss drugs became a scandal in the past, it does not mean that newer drugs will be ineffective.
ChapterThe Problem With Weight-Loss Medications
EpisodeDoctors Have a New Plan for Fat Kids
PodcastMaintenance Phase
Clinical trials screening out people with disabilities and mental health issues in favor of "normal" participants, along with the questionable safety of drugs like semaglutide for adolescents, raise ethical concerns in the medical industry.
51:54 - 57:09 (05:14)
Summary
Clinical trials screening out people with disabilities and mental health issues in favor of "normal" participants, along with the questionable safety of drugs like semaglutide for adolescents, raise ethical concerns in the medical industry.
ChapterThe Problem With Weight-Loss Medications
EpisodeDoctors Have a New Plan for Fat Kids
PodcastMaintenance Phase
The use of weight loss drugs as a monotherapy is not supported by current guidelines.
57:09 - 59:16 (02:07)
Summary
The use of weight loss drugs as a monotherapy is not supported by current guidelines. The comprehensive approach that is needed is often rare in the US healthcare system, but it is necessary for their success.
ChapterThe Problem With Weight-Loss Medications
EpisodeDoctors Have a New Plan for Fat Kids
PodcastMaintenance Phase
New guidelines suggest that children who have a BMI over 35 and a comorbidity such as diabetes or hypertension are eligible for referral to bariatric surgery.
59:16 - 1:01:29 (02:12)
Summary
New guidelines suggest that children who have a BMI over 35 and a comorbidity such as diabetes or hypertension are eligible for referral to bariatric surgery. However, the emotional toll of the surgery can be significant, and some people who have undergone bariatric surgery report feeling sad at how differently they are treated after losing weight.